Literature DB >> 28737420

Platforms and techniques used for biomarker assays: where are we now?

Charles Hottenstein1, Matthew Szapacs1, Kerensa Fuller2, Christopher Evans1.   

Abstract

Keywords:  LC–MS; biomarker; ligand binding assay; parallelism; platform; surrogate analyte; surrogate matrix

Mesh：

Substances：

Year:  2017        PMID： 28737420     DOI： 10.4155/bio-2017-0107

Source DB:  PubMed          Journal:  Bioanalysis        ISSN： 1757-6180            Impact factor:   2.681


× No keyword cloud information.
  1 in total

1.  A comparison of biofluid cytokine markers across platform technologies: Correspondence or divergence?

Authors:  K B Casaletto; F M Elahi; R Fitch; S Walters; E Fox; A M Staffaroni; B M Bettcher; H Zetterberg; A Karydas; J C Rojas; A L Boxer; J H Kramer
Journal:  Cytokine       Date:  2018-06-14       Impact factor: 3.861
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.